Supplemental material
Current Medical Research and Opinion
Volume 40, 2024 - Issue 5
Oncology
Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis
Naoki Miyazakia Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan
https://orcid.org/0000-0001-7753-5191
https://orcid.org/0000-0001-7753-5191, Toshiki Iwasakia Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japanhttps://orcid.org/0000-0001-8377-1406
https://orcid.org/0000-0001-8377-1406, Hitomi Sakaib Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japanhttps://orcid.org/0000-0001-8396-9121
https://orcid.org/0000-0001-8396-9121, Rurina Watanukic Department of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Japanhttps://orcid.org/0000-0002-7462-4137
https://orcid.org/0000-0002-7462-4137, Yoshinori Tanizawad Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0002-5014-2483
https://orcid.org/0000-0002-5014-2483, Zhihong Caid Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0002-3431-197X
https://orcid.org/0000-0002-3431-197X, Tsutomu Kawaguchid Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japanhttps://orcid.org/0000-0001-6182-9005
https://orcid.org/0000-0001-6182-9005, Junji Tsurutanib Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japanhttps://orcid.org/0000-0002-6260-6943
https://orcid.org/0000-0002-6260-6943 & Kengo Nagashimaa Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-4529-9045
https://orcid.org/0000-0003-4529-9045 show all